Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling
暂无分享,去创建一个
N. Sibinga | M. Layne | S. yet | Yen-Hsu Chen | M. Perrella | Yen-Hsu Chen | Matthew D. Layne | Bonna Ith | Shaw-Fang Yet | Mark A. Perrella | Xiaoli Liu | Nicholas E. S. Sibinga | Xiaoli Liu | B. Ith
[1] S. Kourembanas,et al. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. , 1995, The Journal of clinical investigation.
[2] A. Lusis,et al. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.
[3] T. Lüscher,et al. Pulsatile Stretch Stimulates Superoxide Production and Activates Nuclear Factor-κB in Human Coronary Smooth Muscle , 1997 .
[4] S. Shyue,et al. Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2001, Circulation.
[5] Jason L. Johnson,et al. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. , 2001, Atherosclerosis.
[6] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Circulation.
[7] J. Ingwall,et al. Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice , 2001, Circulation research.
[8] H. Rennke,et al. Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice , 2001, Circulation research.
[9] F. Kronenberg,et al. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. , 2001, Atherosclerosis.
[10] L. Kobzik,et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.
[11] James L. Park,et al. Heme oxygenase-1 protects against vascular constriction and proliferation , 2001, Nature Medicine.
[12] A. Choi,et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.
[13] A. Choi,et al. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.
[14] O. Wagner,et al. Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal Angioplasty , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[15] R. Alexander,et al. Functional angiotensin II receptors in cultured vascular smooth muscle cells , 1982, The Journal of cell biology.
[16] H. Marver,et al. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[17] Y. Bobryshev,et al. Structural features of cell death in atherosclerotic lesions affecting long-term aortocoronary saphenous vein bypass grafts. , 1999, Journal of submicroscopic cytology and pathology.
[18] C. T. Wagner,et al. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. , 1997, The Journal of clinical investigation.
[19] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[20] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[21] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[22] Y. Niida,et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.
[23] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[24] S. Tonegawa,et al. Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Beyar,et al. Multivessel coronary artery disease: current revascularization strategies. , 2001, European heart journal.
[26] G. Angelini,et al. Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute. , 2002, Biorheology.
[27] F Unger,et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.
[28] S. Kourembanas,et al. Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.
[29] Tzong-Shyuan Lee,et al. Expression of heme oxygenase-1 in atherosclerotic lesions. , 1998, The American journal of pathology.
[30] W. Pan,et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients , 2002, Human Genetics.
[31] T. Minamino,et al. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Ny,et al. Pitfalls using metalloporphyrins in carbon monoxide research. , 1997, Trends in pharmacological sciences.
[33] P. Carmeliet,et al. Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis. , 1999, Circulation research.
[34] A. Lusis,et al. Heme Oxygenase-1 Inhibits Atherosclerotic Lesion Formation in LDL-Receptor Knockout Mice , 2001, Circulation research.
[35] D. Praticò,et al. Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice , 2002, Circulation.
[36] R. Tyrrell,et al. Rapidly occurring DNA excision repair events determine the biological expression of u.v.-induced damage in human cells. , 1987, Carcinogenesis.
[37] G. Angelini,et al. Towards the prevention of vein graft failure. , 1997, International journal of cardiology.
[38] R. Ross,et al. Cell biology of atherosclerosis. , 1995, Annual review of physiology.
[39] M. Mayr,et al. Rapid development of vein graft atheroma in ApoE-deficient mice. , 2000, The American journal of pathology.
[40] M. Suematsu,et al. Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[41] D. Sugawara,et al. Heme Oxygenase-1 Inhibits Atherogenesis in Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.
[42] S. Hunt,et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[43] B. Ames,et al. Antioxidant activity of albumin-bound bilirubin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[45] E. Haber,et al. Aortic Carboxypeptidase-like Protein, a Novel Protein with Discoidin and Carboxypeptidase-like Domains, Is Up-regulated during Vascular Smooth Muscle Cell Differentiation* , 1998, The Journal of Biological Chemistry.
[46] B. Schreiber,et al. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[47] G. D. De Meyer,et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. , 1996, Circulation.
[48] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[49] M. Maines. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[51] P. Quax,et al. Accelerated Atherosclerosis and Calcification in Vein Grafts: A Study in APOE*3 Leiden Transgenic Mice , 2002, Circulation research.
[52] Tzong-Shyuan Lee,et al. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. , 1999, Circulation.